| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| |
| | | UNI - EN REPORT No | 5 | / | 2013 |
| | |
| | Date of issue: | 2013-01-10 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | Current report 5 buy back 10012013 | |
| | Official market - legal basis | | | | | | |
| | Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
| |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | The Board of Directors of SOPHARMA AD (the “Company") hereby informs that from 3 January 2012 up to and including 9 January 2013 the Company bought 2000 own shares representing 0.0015% of the share capital of the Company, to the total value of BGN 4212.51 on the Bulgarian Stock Exchange. The average price per share was BGN 2.11. | |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| | Current report 5 buy back 10012013.doc | Current report 5 buy back 10012013 | |
